Electrically Evoked Compound Action Potentials Human Observation Medtronic System Study (ECHO-MDT)
ECHO-MDT
1 other identifier
interventional
201
1 country
10
Brief Summary
This is a prospective, multi-center, non-significant risk IDE study of evoked waveforms resulting from stimulation of the dorsal column using a closed-loop system. comprised of Medtronic hardware or off the shelf hardware, which uses recorded waveforms to adjust stimulation amplitude.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable chronic-pain
Started Oct 2019
Longer than P75 for not_applicable chronic-pain
10 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 30, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 16, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 16, 2023
CompletedFirst Submitted
Initial submission to the registry
June 18, 2024
CompletedFirst Posted
Study publicly available on registry
July 12, 2024
CompletedJuly 12, 2024
July 1, 2024
4 years
June 18, 2024
July 8, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Collection of ECAP data (sensing configurations, stimulation parameters eliciting ECAPs, control policies/algorithms for recording ECAPs) via the research system.
The ECAP data collected is prototype system/device information for development of a closed loop system.
1 hour to 72 hours
Study Arms (1)
ECAP Recording
EXPERIMENTALInterventions
Spinal Cord Stimulation (SCS) as an aid in the management of chronic, intractable pain of the trunk and/or limbs.
Eligibility Criteria
You may qualify if:
- years of age or older
- Candidate for or undergoing Medtronic SCS device trial for labeled indication\*
- Willing and able to provide signed and dated informed consent
- Capable of comprehending and consenting in English
- Willing and able to comply with all study procedures and visits \*Candidate for or undergoing Medtronic SCS device trial for labeled indication means that a clinical decision has already been made between a physician and the patient to undergo Medtronic SCS trialing to treat the patient's chronic pain. This decision is to be made prior to discussing with the patient whether to enroll in the study.
You may not qualify if:
- Implanted electrical cardiac device (e.g., pacemaker, defibrillator)
- Currently enrolled or planning to enroll in an interventional clinical study that could potentially confound the study results (co-enrollment in an interventional study is only allowed when documented pre-approval is obtained from the Medtronic study manager or designee)
- Currently diagnosed with a disease that may confound ability to evoke compound action potentials, e.g. multiple sclerosis, as determined by the investigator
- Pregnant or is of child-bearing potential and unwilling to use a medically acceptable form of birth control during the study
- Has untreated major psychiatric comorbidity, as determined by the investigator or designee
- Trialed with a permanent implant lead and extension ("buried lead trial")
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- MedtronicNeurolead
Study Sites (10)
Coastal Pain and Spinal Diagnostics
Carlsbad, California, 92009, United States
MercyOne Des Moines Medical Center
Des Moines, Iowa, 50314, United States
Nura Research Institute
Edina, Minnesota, 55435, United States
Twin Cities Pain Clinic
Edina, Minnesota, 55439, United States
iSpine Pain Physicians
Maple Grove, Minnesota, 55369, United States
The Ohio State University Wexner Medical Center
Columbus, Ohio, 43210, United States
Kettering Health
Kettering, Ohio, 45429, United States
Premier Pain Treatment Institute
Mount Orab, Ohio, 45154, United States
Center for Interventional Pain and Spine
Lancaster, Pennsylvania, 17601, United States
Rockefeller Neuroscience Institute West Virginia University
Morgantown, West Virginia, 26505, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 18, 2024
First Posted
July 12, 2024
Study Start
October 30, 2019
Primary Completion
October 16, 2023
Study Completion
October 16, 2023
Last Updated
July 12, 2024
Record last verified: 2024-07